Alexander KarpAlexander Karp earned $1B in 2024

1+ years at the helm of Outlook Therapeutics, Inc..

Compensation History

Annual executive compensation data for Lawrence A. Kenyon, including salary, bonuses, and stock awards.

No compensation data available for Lawrence A. Kenyon yet. Come back soon!

O

Lawrence A. Kenyon

CEO of Outlook Therapeutics, Inc.

Education

B.A. in Accounting from the University of Wisconsin-Whitewater

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

CEO of Outlook Therapeutics, Inc. for

1 year 0 months (Dec 2024 - Present)

Previous Experience

Unknown

Holdings

Track Lawrence A. Kenyon's stock holdings and portfolio value over time.

Insider Trading

Lawrence A. Kenyon's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Lawrence A. Kenyon with competitor CEOs and industry peers.